SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-18 |
| Reported value | $605,916,390 |
| Positions | 96 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| CG ONCOLOGY INC | CGON | COM | $134,017,068 | 1,886,236 |
| TANGO THERAPEUTICS INC | TNGX | COM | $95,660,985 | 3,228,144 |
| REVOLUTION MEDICINES INC | RVMD | COM | $45,327,191 | 242,029 |
| PHARVARIS N V | PHVS | COM | $26,782,245 | 774,501 |
| LIQUIDIA CORPORATION | LQDA | COM NEW | $20,458,957 | 256,603 |
| ENLIVEN THERAPEUTICS INC | ELVN | COM | $18,543,340 | 365,386 |
| ABIVAX SA | ABVX | SPONSORED ADS | $14,836,369 | 111,334 |
| AVALO THERAPEUTICS INC | AVTX | COM NEW | $14,243,737 | 770,765 |
| MIRUM PHARMACEUTICALS INC | MIRM | COM | $12,923,709 | 110,393 |
| ASSEMBLY BIOSCIENCES INC | ASMB | COM NEW | $11,902,879 | 433,147 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.